Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

EVP, Pres., Novocure Oncology

Chief Operating Officer

Chief Human Resources Officer

Chief Medical Officer

Chief Financial Officer

Chief Innovation Officer

Chief Science Officer

General Counsel

Chief Growth Officer

Chief Executive Officer

President, CNS Cancers US

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. The company was incorporated in 2000 and is headquartered in Saint Helier, Jersey.

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) ...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-04	Premium	sold	Premium	Premium	Premium	EVP, Pres., Novocure Oncology
2024-03-04	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2024-03-01	Premium	sold	Premium	Premium	Premium	EVP, Pres., Novocure Oncology
2024-03-01	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2024-02-28	Premium	sold	Premium	Premium	Premium	EVP, Pres., Novocure Oncology
2024-02-28	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2024-02-27	Premium	acquired	Premium	Premium	Premium	Chief Human Resources Officer
2024-02-27	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2024-02-27	Premium	acquired	Premium	Premium	Premium	EVP, Pres., Novocure Oncology
2024-02-27	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-02-27	Premium	acquired	Premium	Premium	Premium	Chief Innovation Officer
2024-02-27	Premium	acquired	Premium	Premium	Premium	Chief Science Officer
2024-02-27	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2024-02-27	Premium	acquired	Premium	Premium	Premium	General Counsel
2023-12-31	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2023-12-31	Premium	acquired	Premium	Premium	Premium	General Counsel
2023-11-07	Premium	sold	Premium	Premium	Premium	Chief Growth Officer
2023-11-02	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-10-31	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-10-31	Premium	acquired	Premium	Premium	Premium	Chief Human Resources Officer
2023-09-01	Premium	sold	Premium	Premium	Premium	Chief Growth Officer
2023-09-01	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2023-09-01	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2023-08-02	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2023-06-30	Premium	acquired	Premium	Premium	Premium	General Counsel

NVCR - Novocure Ltd Stock Price, Fair Value and News

Latest Insider Trading transactions for NVCR